1 |
Wang L, Zhang H, Ruan Y, et al. Tuberculosis prevalence in China, 1990-2010: a longitudinal analysis of national survey data[J]. Lancet,2014,383(9934):2057-2064.
|
2 |
Pathak V, Shepherd RW, Shojaee S. Tracheobronchial tuberculosis[J]. J Thorac Dis,2016,8(12):3818-3825.
|
3 |
Castro AT, Mendes M, Freitas S, Incidence and risk factors of major toxicity associated to first-line anti-tuberculosis drugs for latent and active tuberculosis during a period of 10 years[J]. Rev Port Pneumol,2015,21(3):144-150.
|
4 |
Johnston A, Uetrecht J. Current understanding of the mechanisms of drug-induced agranulocytosis[J]. Expert Opin Drug Metab Toxicol,2015,11(2):245-257.
|
5 |
Aapro MS, Bohlius J, Cameron DA, et al. 2010 update of EORTC guidelines for the use of granulocyte-colony stimulating factor to reduce the incidence of chemotherapy-induced febrile neutropenia in adult patients with lymphoproliferative disorders and solid tumours[J]. Eur J Cancer,2011,47(1):8-32.
|
6 |
Crawford J, Caserta C, Roila F, et al. Hematopoietic growth factors: ESMO Clinical Practice Guidelines for the applications[J]. Ann Oncol,2010,21(Suppl 5):S248-S251.
|
7 |
陈灏珠,钟南山,陆再英, 等. 内科学[M]. 8版. 北京: 人民卫生出版社,2013:61-573.
|
8 |
Van der Walt M, Lancaster J, Odendaal R, et al. Serious treatment related adverse drug reactions amongst anti-retroviral native MDR-TB patients[J]. PLos One,2013,8(4):e58817.
|
9 |
Shen T, Gu D, Zhu Y, et al. The value of eosinophil VCS parameters in predicting hepatotoxicity of anti-tuberculosis drugs[J]. Int J Lab Hematol,2016,38(5):514-519.
|
10 |
Martineau AR, Newton SM, Wilkinson KA, et al. Neutrophil mediated innate immune resistance to mycobacteria[J]. J Clin Invest,2007,117(7):1988-1994.
|
11 |
Dallenga T, Sahaible UE. Neutrophils in tuberculosis--first line of defence or booster of disease and targets for host-directed therapy?[J]. Pathog Dis,2016,74(3):12.
|
12 |
刘文,杨金边,刘米佳, 等. 门诊抗结核治疗致白细胞降低130例分析及对策[J]. 临床肺科杂志,2011,16(5):724-725.
|
13 |
Griffin PR, Neal SY. 贝塞斯达临床血液学手册[M]. 2版. 北京: 科学出版社,2012:149-155.
|
14 |
Pick A, Nystrom K. Nonchemotherapy drug-induced neutropenia and agranulocytosis: could medications be the culprit?[J]. J Pharm Pract,2014,27(5):447-452.
|
15 |
Yoo N, Lee HR, Sc KY, et al. PLAG (1-palmitoyl-2-linoleoyl-3-acetyl-rac-glycerol) augments the therapeutic effect of pegfilgrastim on gemcitabine-induced neutropenia[J]. Cancer Lett,2016,377(1):25-31.
|
16 |
Jaillon S, Galdiero MR, Del P, et al. Neutrophils in innate and adaptive immunity[J]. Semin immunopathol,2013,35(4):377-394.
|
17 |
Bian Z, Guo Y, Ha B, et al. Regulation of the inflammatory response: nhancing neutrophil infiltration under chronic inflammatory conditions[J]. J Immunol,2012,188(2):844-853.
|
18 |
徐晓萌,李俊明. 中性粒细胞在结核病免疫中的作用及其研究进展[J]. 细胞与分子免疫学杂志,2014,30(8):885-887.
|
19 |
Gonzalez-Cano P, Mondragon-Flores R, Sanchez-Torres LE, et al. Mycobacterium tuberculosis H37Rv induces ectosome release in human polymorphonuclear neutrophils[J]. Tuberculosis (Edinb),2010,90(2):125-134.
|
20 |
Andersohn F, Konzen C, Garbe E. Systematic review: agranulocytosis induced by nonchemotherapy drugs[J]. Ann Intern Med,2007,146(9):657-665.
|
21 |
Hu X, Zhou H, Zhang D, et al.Clozapine protects dopaminergic neurons from inflammationinduced amage by inhibiting microglial overactivation[J]. J NeuroImmune Pharmacol,2012,7(1):187-201.
|
22 |
Mourot-Cottet R, Maloisel F, Severac F, et al. Idiosyncratic drug-induced severe neutropenia and agranulocytosis in elderly patients (≥75 years): a monocentric cohort study of 61 cases[J]. Drugs Real World Outcomes,2016,3(4):393-399.
|
23 |
Ribeiro BM, do Carmo MR, Freire RS, et al. Evidences for a progressive microglial activation and increase in iNOS expression in rats submitted to a neurodevelopmental model of schizophrenia: reversal by clozapine[J]. Schizophr Res,2013,151(1-3):12-19.
|
24 |
Zhu Y, Cao X, Fang Y, et al. Mean monocyte volume is significantly increased in post-surgical bacterial infection[J]. Int J Lab Hematol,2015,37(6):e145-e146.
|
25 |
Zhu Y, Cao X, Zhang K, et al. Delta mean neutrophil volume (△MNV) is comparable to procalcitonin for predicting postsurgical bacterial infection[J]. Clin J Lab Analy,2014,28(4):301-305.
|
26 |
Bagdasaryan R, Zhou ZR, Tierno B, et al. Neutrophil VCS parameters are superior indicators for acute infection[J]. Lab Hematol,2007,13(1):12-16.
|
27 |
Cormican LJ, Schey S, Milburn HJ, et al. G-CSF enables completion of tuberculosis therapy associated with iatrogenic neutrooenia[J]. Eur Respir J,2004,23(4):649-650.
|
28 |
Petru E, Singer CF, Polterauer S, et al. Prophylactic long-acting granulocyte-colony stimulating factors (G-CSF) in gynecologic malignancies: an oncologic expert statement[J]. Wien Med Wochenschr,2015,165(19-20):387-394.
|